NasdaqGS:HCATHealthcare Services
Health Catalyst (HCAT) Trailing EPS Loss Worsens And Reinforces Bearish Profitability Narratives
Health Catalyst (HCAT) opened Q1 2026 with total revenue of US$70.8 million and a basic EPS loss of US$1.53, setting a clear tone for another quarter where the income statement remains under pressure. Over recent periods, revenue has moved from US$79.4 million in Q1 2025 through US$80.7 million in Q2 2025 and US$76.3 million in Q3 2025 to US$74.7 million in Q4 2025. Basic EPS losses shifted from US$0.35 in Q1 2025 to US$0.59 in Q2 2025, US$0.32 in Q3 2025 and US$1.28 in Q4 2025, giving...